(HealthDay)—C-reactive protein (CRP) levels are an independent prognostic marker in melanoma, according to a study published online March 16 in the Journal of Clinical Oncology.
Shenying Fang, M.D., Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the correlation between CRP and survival in patients with melanoma. CRP was determined from two independent sets of plasma samples from 1,144 patients with melanoma (587 initial and 557 confirmatory). The correlation between CRP and clinical outcome was assessed. Nonparametric tests were used to assess the relationship between change in disease status and change in CRP in 115 patients who underwent sequential blood draws.
The researchers found that elevated CRP correlated with poorer overall survival (OS) and melanoma-specific survival (MSS) in the initial, confirmatory, and combined data sets (combined data set: OS hazard ratio, 1.44 per unit increase of logarithmic CRP; MSS hazard ratio, 1.51 per unit increase of logarithmic CRP; both P < 0.001). After multivariable adjustment these findings persisted. CRP ≥10 mg/L conferred poorer OS in patients with any-stage, stage I/II, or stage III/IV disease and poorer disease-free survival in those with stage I/II disease, compared with CRP <10 mg/L. There was a correlation noted between increase in CRP and melanoma disease progression among those with sequential evaluation of CRP.
"CRP measurement should be considered for incorporation into prospective studies of outcome in patients with melanoma and clinical trials of systemic therapies for those with melanoma," the authors write.
Several authors disclosed financial ties to the pharmaceutical, biopharmaceutical, and health care industries.
Explore further: CRP/ESR disagreement common in infection, inflammation
More information: Abstract
Full Text (subscription or payment may be required)
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
CRP/ESR disagreement common in infection, inflammation
Jan 16, 2015
(HealthDay)—For patients with suspected infection or inflammation, C-reactive protein (CRP)/erythrocyte sedimentation rate (ESR) disagreement is common, according to a study published online Dec. 31 in ...
High-intensity statin effect independent of lipoprotein, CRP
Nov 13, 2014
(HealthDay)—High-intensity statin therapy is associated with coronary atherosclerosis regression, regardless of baseline lipoprotein or C-reactive protein (CRP) levels, according to a study published in ...
C-reactive protein levels predict breast cancer survival rates
Jun 03, 2011
Levels of C-reactive protein (CRP) are increased in response to acute inflammation, infection and tissue damage. There are also reports that CRP levels are elevated because of cancer. New research published in BioMed Central's ...
Birth weight, breastfeeding linked to C-reactive protein
May 12, 2014
(HealthDay)—Higher birth weight and having been breastfed for three or more months correlate with lower C-reactive protein (CRP) concentration in young adulthood, according to a study published online April ...
CRP genetic variants crucial in interpreting inflammatory disease activity
Sep 21, 2010
CRP is commonly used as a serum marker for inflammation or infection, but the genetic effects of CRP variants on acute-phase serum CRP concentrations in patients with rheumatoid arthritis may be large enough to have a clinically ...
Recommended for you
Doctors say women with aytpia or DCIS should seek second opinions after breast biopsies
29 minutes ago
While doctors almost always agree on a pathological diagnosis of invasive breast cancer, there is room for improvement when diagnosing atypia (or atypical ductal hyperplasia-ADH) and DCIS (ductal carcinoma in-situ), Anna ...
mHealth app ideal for breast cancer risk assessment, prevention
45 minutes ago
Interviewing women at a breast-imaging center in an urban safety net institution before and after they used a "mHealth" mobile health app on a tablet, Elissa Ozanne, PhD from Dartmouth's Norris Cotton Cancer Center and colleagues ...
Study uncovers mechanisms of cancer-causing mutations
2 hours ago
Researchers at the San Diego Supercomputer Center (SDSC) and the Moores Cancer Center at the University of California, San Diego, have described for the first time the molecular mechanism of cancer development ...
Blood test replaces surgery for bowel tumor assessment
6 hours ago
A new study at the MedUni Vienna's Comprehensive Cancer Center (CCC) is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance ...
Breakthrough for leukaemia suffers
6 hours ago
A research team has found a way to ensure people suffering from leukaemia are not subjected to chemotherapy if it is unlikely to help them.
Predicted deaths of young women with breast cancer underestimated by a quarter
7 hours ago
An online computer programme that helps to predict the most suitable treatment for breast cancer has been found to underestimate the number of women under 40 who will die from the disease by 25 per cent, ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
(HealthDay)—C-reactive protein (CRP) levels are an independent prognostic marker in melanoma, according to a study published online March 16 in the Journal of Clinical Oncology.
Shenying Fang, M.D., Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues examined the correlation between CRP and survival in patients with melanoma. CRP was determined from two independent sets of plasma samples from 1,144 patients with melanoma (587 initial and 557 confirmatory). The correlation between CRP and clinical outcome was assessed. Nonparametric tests were used to assess the relationship between change in disease status and change in CRP in 115 patients who underwent sequential blood draws.
The researchers found that elevated CRP correlated with poorer overall survival (OS) and melanoma-specific survival (MSS) in the initial, confirmatory, and combined data sets (combined data set: OS hazard ratio, 1.44 per unit increase of logarithmic CRP; MSS hazard ratio, 1.51 per unit increase of logarithmic CRP; both P < 0.001). After multivariable adjustment these findings persisted. CRP ≥10 mg/L conferred poorer OS in patients with any-stage, stage I/II, or stage III/IV disease and poorer disease-free survival in those with stage I/II disease, compared with CRP <10 mg/L. There was a correlation noted between increase in CRP and melanoma disease progression among those with sequential evaluation of CRP.
"CRP measurement should be considered for incorporation into prospective studies of outcome in patients with melanoma and clinical trials of systemic therapies for those with melanoma," the authors write.
Several authors disclosed financial ties to the pharmaceutical, biopharmaceutical, and health care industries.
Explore further: CRP/ESR disagreement common in infection, inflammation
More information: Abstract
Full Text (subscription or payment may be required)
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
CRP/ESR disagreement common in infection, inflammation
Jan 16, 2015
(HealthDay)—For patients with suspected infection or inflammation, C-reactive protein (CRP)/erythrocyte sedimentation rate (ESR) disagreement is common, according to a study published online Dec. 31 in ...
High-intensity statin effect independent of lipoprotein, CRP
Nov 13, 2014
(HealthDay)—High-intensity statin therapy is associated with coronary atherosclerosis regression, regardless of baseline lipoprotein or C-reactive protein (CRP) levels, according to a study published in ...
C-reactive protein levels predict breast cancer survival rates
Jun 03, 2011
Levels of C-reactive protein (CRP) are increased in response to acute inflammation, infection and tissue damage. There are also reports that CRP levels are elevated because of cancer. New research published in BioMed Central's ...
Birth weight, breastfeeding linked to C-reactive protein
May 12, 2014
(HealthDay)—Higher birth weight and having been breastfed for three or more months correlate with lower C-reactive protein (CRP) concentration in young adulthood, according to a study published online April ...
CRP genetic variants crucial in interpreting inflammatory disease activity
Sep 21, 2010
CRP is commonly used as a serum marker for inflammation or infection, but the genetic effects of CRP variants on acute-phase serum CRP concentrations in patients with rheumatoid arthritis may be large enough to have a clinically ...
Recommended for you
Doctors say women with aytpia or DCIS should seek second opinions after breast biopsies
29 minutes ago
While doctors almost always agree on a pathological diagnosis of invasive breast cancer, there is room for improvement when diagnosing atypia (or atypical ductal hyperplasia-ADH) and DCIS (ductal carcinoma in-situ), Anna ...
mHealth app ideal for breast cancer risk assessment, prevention
45 minutes ago
Interviewing women at a breast-imaging center in an urban safety net institution before and after they used a "mHealth" mobile health app on a tablet, Elissa Ozanne, PhD from Dartmouth's Norris Cotton Cancer Center and colleagues ...
Study uncovers mechanisms of cancer-causing mutations
2 hours ago
Researchers at the San Diego Supercomputer Center (SDSC) and the Moores Cancer Center at the University of California, San Diego, have described for the first time the molecular mechanism of cancer development ...
Blood test replaces surgery for bowel tumor assessment
6 hours ago
A new study at the MedUni Vienna's Comprehensive Cancer Center (CCC) is assessing patients with metastasised bowel cancer to determine whether it is possible to characterise tumour and better control resistance ...
Breakthrough for leukaemia suffers
6 hours ago
A research team has found a way to ensure people suffering from leukaemia are not subjected to chemotherapy if it is unlikely to help them.
Predicted deaths of young women with breast cancer underestimated by a quarter
7 hours ago
An online computer programme that helps to predict the most suitable treatment for breast cancer has been found to underestimate the number of women under 40 who will die from the disease by 25 per cent, ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment